Results 91 to 100 of about 27,075 (176)

Multiplexing for Plasmodium spp.? Think Again! Comment on Bhowmick et al. Dry Post Wintertime Mass Surveillance Unearths a Huge Burden of P. vivax, and Mixed Infection with P. vivax P. falciparum, a Threat to Malaria Elimination, in Dhalai, Tripura, India. Pathogens 2021, 10, 1259 [PDF]

Pathogens, 2022
Deora N, Kar S, Sinha A.
europepmc   +1 more source

Revisiting the applicability of minisatellite marker CH1T1M13779 to investigate the genetic diversity of P. vivax in Nuh district, Haryana, India. [PDF]

One Health Outlook
Das R, Vashisht K, Savargaonkar D, Gupta Y, Kumar J, Harit R, Chandra S, Arya A, Tiwari VK, Pandey KC.   +9 more
europepmc   +1 more source

The Drug Resistance of Plasmodium falciparum and P. vivax in Iran: A Review Article. [PDF]

Iran J Parasitol, 2021
Heidari A, Keshavarz H.
europepmc   +1 more source

A common DNA deletion altering the 3'UTR of mdr1 is associated with reduced mefloquine susceptibility in P. vivax parasites from Cambodian patients. [PDF]

Nat Commun
Ko K, Tebben K, Andrianinarivomanana T, Orban A, Grünebast J, Eng V, Eam R, Khim N, Feufack-Donfack LB, Salvador J, Sa JM, Wellems TE, Lek D, Popovici J, Serre D.   +14 more
europepmc   +1 more source

Immunogenicity of full-length P. vivax rPvs48/45 protein formulations in BALB/c mice. [PDF]

Vaccine, 2022
Arévalo-Herrera M, Miura K, Solano E, Sebastián Ramírez J, Long CA, Corradin G, Herrera S.   +6 more
europepmc   +1 more source

Systems approach identifies monocyte imbalance in symptomatic and asymptomatic P. vivax malaria. [PDF]

Mol Syst Biol
Studniberg SI, Bafit M, Ioannidis LJ, Worley MJ, Trianty L, Utami RAS, Puspitasari AM, Apriyanti D, Coutrier FN, Poespoprodjo JR, Kenangalem E, Andries B, Prayoga P, Price RN, Noviyanti R, Garnham AL, Hansen DS.   +16 more
europepmc   +1 more source

The use of a chimeric antigen for Plasmodium falciparum and P. vivax seroprevalence estimates from community surveys in Ethiopia and Costa Rica. [PDF]

PLoS One, 2022
McCaffery JN, Singh B, Nace D, Assefa A, Hwang J, Plucinski M, Calvo N, Moreno A, Udhayakumar V, Rogier E.   +9 more
europepmc   +1 more source

Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination. [PDF]

Sci Rep
Wongsurawat T, Jenjaroenpun P, Suwannasin K, Wankaew N, Sanguansakpakdee N, Amornpornviwat T, Dondorp AM, Day NPJ, Nosten F, White NJ, Imwong M.   +10 more
europepmc   +1 more source

Reply to Deora et al. Multiplexing for Plasmodium spp.? Think Again! Comment on "Bhowmick et al. Dry Post Wintertime Mass Surveillance Unearths a Huge Burden of P. vivax, and Mixed Infection with P. vivaxP. falciparum, a Threat to Malaria Elimination, in Dhalai, Tripura, India. Pathogens 2021, 10, 1259". [PDF]

Pathogens, 2022
Pal-Bhowmick I, Nirmolia T, Pandey A, Subbarao SK, Nath A, Senapati S, Tripathy D, Pebam R, Nag S, Roy R, Dasgupta D, Debnath J, Gogoi K, Gogoi K, Borah L, Chanda R, Borgohain A, Mog C, Sarkar U, Gogoi P, Debnath B, Debbarma J, Ranjan Bhattacharya D, Joshi PL, Kaur H, Narain K.   +25 more
europepmc   +1 more source

VAR2CSA-reactive IgG in Brazilian women exposed to <i>Plasmodium falciparum</i> or <i>P. vivax</i> infection during pregnancy. [PDF]

Infect Immun
Dos Santos MI, Dombrowski JG, Hoffmann-Veltung H, Quintana MdP, Marinho CRF, Hviid L, Lopez-Perez M.   +6 more
europepmc   +1 more source